Arkolith/Funds/Knoll Capital Management, LLC

Knoll Capital Management, LLC

CIK 1325083
Holdings as of Mar 31, 2026·disclosed May 15, 2026·~45-day 13F lag·13F-HR
Active Filer

Knoll Capital Management, LLC holds a focused book of 37 stocks worth $180.2M as of Q1 2026 (disclosed May 15, 2026, a ~45-day 13F lag). This quarter they opened Sprott Physical Gold Trust and trimmed Kinross Gold Corp. Their largest long position is Biohaven Pharmaceutical Hold at 11% of the equity book.

Build

Build on this 13F portfolio

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Build

Ask your agent what Knoll Capital Management, LLC owns

This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/funds/1325083/holdings"
Ask your agent
Use Arkolith to show Knoll Capital Management, LLC's latest
holdings, largest changes, and filing provenance.
Opened
8
new positions
Added to
3
existing
Trimmed
3
reduced
Sold out
4
exited

Concentration

Top-heavy: focused book

Top 5 holdings
38%
Top 10 holdings
62%
Top 20 holdings
91%

Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.

Direct sector allocation

88% mapped to company sectors

Materials
35%
Health Care
26%
Financials
25%
ETF / fund or unclassified
12%
Consumer Staples
1%
Information Technology
1%
Industrials
1%

Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.

Biggest moves: latest quarter

Estimated $ traded · quarter-end prices, no cost basis

Bought
Trimmed / exited

Holdings: largest first

Bars show each stock's share of the portfolio. Click a row for its position history.

37 positions
#SecurityValueShares% PortLast moveHistory
1Biohaven Pharmactl Hldg Co
COM
$19.7M2.33M
10.9%
Held
2Sprott physical gold Trust
Physical Gold Tr
$13.7M387.1K
7.6%
New
New position
3Royal Gold Inc.
COM
$13.4M52.8K
7.5%
Held
4MeiraGTX Holdings
COM
$10.8M1.25M
6.0%
Held
5Agnico Eagle Mines Ltd
COM
$10.7M52.8K
5.9%
Held
6Kinross Gold Corp
COM
$9.8M320.0K
5.4%
−22%
Reduced · −90K sh
7Aldeyra Therapeutics Inc
COM
$9.3M5.48M
5.1%
Held
8Seabridge Gold Inc
COM
$9.0M317.0K
5.0%
Held
9Franco Nev Corp
COM
$7.9M32.0K
4.4%
+28%
Added · +7K sh
10SSR Mining In
COM
$7.2M245.0K
4.0%
Held
11Elicio Therapeutics Inc
COM
$6.7M630.9K
3.7%
Held
12Entera Bio Ltd
SHS
$6.5M5.88M
3.6%
Held
13Nuvation Bio Inc
COM CL A
$6.4M1.50M
3.6%
Held
14Centerra Gold Inc
COM
$6.4M359.0K
3.5%
−28%
Reduced · −138K sh
15Pan American Silver
COM
$5.5M100.0K
3.0%
Held
16Sprott Physical silver Trust
Physical Silver
$5.4M222.2K
3.0%
New
New position
17Ocular Therapeutix Inc.
COM
$5.1M600.4K
2.8%
Held
18Triple Flag Precious Metals
COM
$4.0M115.0K
2.2%
+96%
Added · +56K sh
19Gold RTY Corp
COM
$3.6M1.00M
2.0%
New
New position
20Alamos Gold Inc
COM CL New
$2.2M50.0K
1.2%
Held
21Abeona Therapeutics
COM NEW
$2.2M485.5K
1.2%
+106%
Added · +250K sh
22New Pac Metals Corp
COM
$2.0M485.0K
1.1%
Held
23Coeur Mining Inc
COM NEW
$1.8M96.1K
1.0%
Held
24iSHares US Aerospace & Defense
US AER DEF ETF
$1.7M7.7K
0.9%
Held
25Philip Morris Intl. Inc
COM
$1.7M10.0K
0.9%
Held
26Wheaton Precious Metals Corp
COM
$1.6M12.5K
0.9%
Held
27Northrop Grumman Corp
COM
$1.5M2.2K
0.8%
Held
28Booz Allen Hamilton HLDG COR
CL A
$1.0M13.0K
0.6%
Held
29Elemental RTY Corp
COM NEW
$943K50.0K
0.5%
New
New position
30Versamet Royalties Corp
COM NEW
$634K66.6K
0.4%
New
New position
31Dakota Gold Corp
COM
$621K122.9K
0.3%
Held
32Amrize LTD
SHS
$514K9.2K
0.3%
New
New position
33Altimmune Inc
COM NEW
$493K160.0K
0.3%
−86%
Reduced · −962K sh
34Cardiol Therapeutics Inc
COM Cal A
$135K100.0K
0.1%
Held
35Pharming Group NV
SPON ADS
$68K4.1K
0.0%
New
New position
36Orgenesis, Inc.
COM
$30K50.6K
0.0%
Held
37OR Royalties
COM SHS
$9K225.0K
0.0%
New
New position
Showing all 37 positions

Filing history

As-of date vs the date the SEC received each filing

QuarterAs ofFiledPositionsValueForm
Q1 2026Mar 31, 2026May 15, 202637$180.2M13F-HR
Q4 2025Dec 31, 2025Feb 17, 202634$218.0M13F-HR
Q3 2025Sep 30, 2025Nov 14, 202539$186.6M13F-HR
Q2 2025Jun 30, 2025Aug 14, 202538$140.7M13F-HR

Data source

Holdings from SEC EDGAR 13F-HR filings, updated quarterly ~45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. Price-derived performance is withheld until the price-source policy and freshness gate are green.